All Type of News
About 40 generic companies enters ‘Twynsta’ market
Generics of ‘Twynsta(telmisartan, amlodipine),’ a leading drug in the hypertension complex market, are getting ready to be released.
As Twynsta lost the exclusivity with the expiration of the PMS(post-marketing surve...
Hanmi Pharm signs anticancer technology export of KRW 1 trillion with GenentechHanmi Pharm announced conclusion of a license agreement for the development and commercialization of HM95573, a targeted therapy under development for Phase 1 clinical trials, w... |
GE Healthcare establishes ‘APAC Fast Track Center’ in Song-do
GE Healthcare announced it selected Korea as a biopharmaceutical hub for the Asia Pacific(APAC) region and decided to accelerate growth of the Korean biopharmaceutical industry by establishing an educational institute...
Pfizer Pharmaceuticals Korea keeps current corporate organization without divisionPfizer Pharmaceuticals Korea announced a plan to keep the current single corporate system of ‘Pfizer Pharmaceuticals Korea.’
The company revealed the Pfizer Group’s result of d... |
Focusing on lecture & consulting fees, admin. investigation be effective to find rebates?
Mentioned at the recent National Inspection, administrative investigation on multinational pharmaceutical companies will conducted on a basis of lecture and consulting fees. A part of the industry, however, has a skep...
“Clinical trials led by researchers with characteristic as donation have risks to violate Kim Young-Ran Law”
An argument was suggested that there is a chance for clinical trials led by researchers with the characteristics of donation to violate the Bribery Prohibition Law.
The Transparent Pharmaceutical Business Network hel...
Enforcement of Bribery Prohibition Law makes everyone call ‘Dutch-paying’
“I guess we should start to go out for dinner with people close.”
After enforcement of the Bribery Prohibition Law, a whole new day has started.
While people are having lunch and dinner within the limit of the law, ...
Champix generics’ attempt to launch early, challenged by 14 companies
After challenges have been made to the substance patent of the Pfizer’s antismoking treatment Champix, other 14 Korean companies participated in the attempt. Once they get successful in the challenge, Champix generics...
Zuellig, “Novartis is only former minority shareholder which already transferred shares back to us”
Zuellig Pharma Korea announced an official position about its relationship with Novartis, which was indicated at the Ministry of Health and Welfare’s National Inspection.
On the 29th, Zuellig announced “We found unt...
3-way competition among Boehringer, Astra & MSD over new antidiabetic complexes
In the Korean diabetes treatment market, a 3-way competition is expected among complexes in combination with DPP-4 and SGLT-2 inhibitors.
According to MSD, ‘ertugliflozin,’ a SGLT-2 inhibitor jointly being developed ...
Which are outstanding tetravalent vaccines even for the young?
Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer
Who will be the next Pharmaceutical Safety Bureau Director?
Celltrion completes clinical trials for Remsima SC for European approval
Sales listed pharmas made in the first half of the year
April
January
February
March
April
May
June
July
August
September
October
November
December
2025
1950
1951
1952
1953
1954
1955
1956
1957
1958
1959
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
2046
2047
2048
2049
2050
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
|---|---|---|---|---|---|---|
30 | 31 | 1 | 2 | 3 | 4 | 5 |
6 | 7 | 8 | 9 | 10 | 11 | 12 |
13 | 14 | 15 | 16 | 17 | 18 | 19 |
20 | 21 | 22 | 23 | 24 | 25 | 26 |
27 | 28 | 29 | 30 | 1 | 2 | 3 |
00:00
01:00
02:00
03:00
04:00
05:00
06:00
07:00
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
21:00
22:00
23:00
